Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
13,290.00    56.00 (0.42%)
Bid:
13,338.00
Ask:
13,344.00
Spread: 6.00 (0.045%)
Market Cap: £206.11b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

GLOBAL MARKETS-Stocks dip after US-Iran peace talks delay; yen nears 40-year lows 
3 days ago

GLOBAL MARKETS-Stocks dip after US-Iran peace talks delay; yen nears 40-year lows 

* Vance pulls out of Friday talks with Iran, oil erases earlier losses

WINNERS & LOSERS: Broker downgrade hits Admiral; PPHE bid collapses
3 days ago

WINNERS & LOSERS: Broker downgrade hits Admiral; PPHE bid collapses

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

Moderna's mRNA flu vaccine backed by FDA advisers
4 days ago

Moderna's mRNA flu vaccine backed by FDA advisers

* ⁠FDA advisers back mFlusiva's benefits for adults 50 and up

AstraZeneca's Ultomiris wins US FDA priority review in kidney disease
15 Jun 2026

AstraZeneca's Ultomiris wins US FDA priority review in kidney disease

(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologic...

AstraZeneca says Truqap combination approved in US for prostate cancer
12 Jun 2026

AstraZeneca says Truqap combination approved in US for prostate cancer

(Alliance News) - AstraZeneca PLC on Friday said a Truqap combination has been approved by the US Food & Drug Administration as a first and only targe...

LONDON MARKET CLOSE: FTSE soars on peace hope as SpaceX IPO blasts off
12 Jun 2026

LONDON MARKET CLOSE: FTSE soars on peace hope as SpaceX IPO blasts off

(Alliance News) - The FTSE 100 ended the week on the front foot as Iran claimed a deal with the US has "never been closer", while investors were glued...

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal
11 Jun 2026

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

* Deal deepens oncology push under CEO Luke Miels

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal
11 Jun 2026

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

* Deal deepens oncology push under CEO Luke Miels